baber/WOPTO huggingface dataset:
Patent PT-1337260-E (PT)
Inventor: LUIGI MERCURI
IPC: A61K31/716
Filed: 2000-11-22
Abstract: A product to be administered by nose for preventing inflammatory or hypertrophic forms and strengthening the immune action in the Waldeyer's ring and the oronasal mucosa consists of a physiological action with a high concentration in a polysaccharide such as glucan. In particular, two solutions having different concentrations have been specified, namely a first physiological solution with a glucan concentration equal to 0.25 % for cleaning the nasal fossae and with a preventive hydrating, reepithelializing capability of strengthening the immune action in the Waldeyer's ring and the oronasal mucosa, and a physiological solution with a glucan concentration equal to 2 % for hydrating and reepithelializing the nasal mucosa, capable of strengthening the immune response in the Waldeyer's ring duringthe acute phase of the inflammatory, hypertrophic forms of the same. Glucan is preferably used in the form  beta -(1-3)-glucan.
Patent PT-1217315-E (PT)
Inventor: REICHERT WERNER
IPC: F24S10/75
Filed: 2001-11-24
Abstract: The invention relates to a solar collector element having an absorber part and a tube for a heat transfer liquid connected thereto on a first side. The absorber part consisting of a composite material having a metallic substrate and an optically active coating on a second side of the substrate. The coating is a multilayer system having three layers. The top layer is a dielectric layer, preferably an oxide, fluoride or nitride layer of chemical composition MeOz, MeFr, MeNs, having a refractive index n<1.8. The middle layer is a chromium oxide layer of chemical composition CrOx. The bottom layer is gold, silver, copper, chromium, aluminium and/or molybdenum. The indices x, z, r and s indicate a stoichiometric or non-stoichiometric ratio in the oxides, fluorides or nitrides.
Patent PT-1257766-E (PT)
Title: Fibre-reinforced pressure vessel and method of manufacturing fibre-reinforced pressure vessel
Inventor: DEBECKER ANDY
IPC: F16J12/00
Filed: 2001-02-01
Abstract: The invention relates to a fibre-reinforced pressure vessel ( 1, 6 ) comprising a rigid gas- of fluid-tight body ( 2, 7, 13, 19 ) overwound with fibre filaments ( 3, 10,11, 18 ), whereby the fibre filaments are wound such that at least a number of fibre filaments can freely move with respect to one another and when the pressure vessel is under internal pressure the fibre filaments are loaded exactly in their longitudinal direction. The invention also relates to a method of manufacturing a fibre-reinforced pressure vessel whereby no matrix material (for example, resin) is used so that at least a number of fibre filaments would be incorporated in a matrix for that section of the pressure vessel in which the fibre filaments can freely move with respect to one another.
Patent PT-1250270-E (PT)
Inventor: ODET PHILIPPE
IPC: B65D47/12
Filed: 2001-01-23
Abstract: A closure divice for a container including a pourer designed to be fixed on a neck of the container wherein the closure device includes a cover assembly adapted to be mounted on the neck and over the pourer. The cover assembly includes a cap movable between a first position wherein it closes the neck and the pourer from the outside and a second position where it allows access to the neck and to the pourer. The pourer is arranged at least partly inside the neck. The cap is provided with a skirt extending, in the first position of the cap, inside the neck. The skirt has at least one flange capable, when the cap is in the first position, of exerting a force urging the pourer against an edge of the neck.
Patent PT-1283043-E (PT)
Title: Ophthalmic solution
Inventor: NAKAYAMA HISAYUKI
IPC: A61K9/00
Filed: 2001-05-16
Abstract: The present invention provides an ophthalmic solution containing pranoprofen or a pharmacologically acceptable salt thereof, and a vasoconstrictor, which is effective for ameliorating congestion in outer ocular areas, particularly conjunctiva and pericorneal area.
Patent PT-1326664-E (PT)
Title: Pen device for administration of parathyroid hormone
Inventor: ROE MICHAEL JOSEPH
IPC: A61M5/24
Filed: 2001-09-26
Abstract: A pen delivery device and a procedure for administering parathyroid hormone is provided to allow for the priming and injection of a single predetermined dose. The method is a three-step method using visual indicators to set the priming and injectable dose deliveries. The device is made of a minimal number of parts, which include a housing, a dose knob, a generally cylindrical disengaging assembly located within the proximal end of the dose knob, and an externally threaded drive stem. The pen device further includes a mechanism that prevents the user from dialing up a dosage greater than that remaining in the cartridge.
Patent PT-1440200-E (PT)
Inventor: LAL OSWAL JANGI
IPC: D06B23/00
Filed: 2001-10-31
Abstract: A process for the preparation of indigo dyed yarn for use in the manufacture of knitted fabric by a knitting machine comprising in the steps of, forming a dyed rope of yarn by the steps of indigo dyeing; individualizing the yarn of said dyed rope; forming separate packages of the yarn on separate spools of fixed ends; preparing individual hanks of each yarn end of each spool by hank maker; converting said hanks into individual cones of single yarn.
Patent PT-1362105-E (PT)
Title: Anti-interferon-alpha antibodies
Inventor: CHUNTHARAPAI ANAN
IPC: C07K19/00
Filed: 2002-01-29
Abstract: The present invention relates generally to the generation and characterization of neutralizing anti-IFN-± monoclonal antibodies with broad reactivity against various IFN-± subtypes. The invention further relates to the use of such anti-IFN-± antibodies in the diagnosis and treatment of disorders associated with increased expression of IFN-±, in particular, autoimmune disorders such as insulin-dependant diabetes mellitus (IDDM) and systemic lupus erythematosus (SLE).
Patent PT-1541044-E (PT)
Title: Filter for cigarette
Inventor: SASAKI TAKASHI
IPC: A24D3/06
Filed: 2003-09-12
Abstract: A cigarette filter has a filter medium containing an inorganic basic substance such as sodium carbonate and a moisturizing agent selected from the group consisting of glycerin, sodium propionate and sodium lactate. <IMAGE>
Patent PT-1631365-E (PT)
Title: Image capturing card shuffler
Inventor: HESSING LYNN
IPC: A63F1/18
Filed: 2003-05-30
Abstract: A card shuffling apparatus (100) comprising: a housing (15), a card input receptacle (50) located on said housing adapted to receive at least one deck of unshuffled playing cards a shuffling device (20) adapted to receive the cards from said card input receptacle, a controller (10) disposed within said housing, image capturing means (30) disposed within said housing for obtaining image data of a playing card, display means (42) located on said housing for displaying images captured by said image capturing means; and a card output bin (60) adapted to discharge shuffle playing cards.
Patent PT-1646564-E (PT)
Title: A roller for transferring labels
Inventor: MARASTONI DANIELE
IPC: B65C9/18
Filed: 2004-05-27
Abstract: A roller (1) for transferring labels of the suction type, comprising a lateral surface (21) having a plurality of openings (2) communicating with respective suction conduits (3) to maintain a label adhering to said lateral surface (21). Originally, at least one of the suction conduits (3) is provided with at least an additional opening (5) located in a position that cannot be obstructed by the label adhering to the lateral surface (21) of the roller (1), to maintain said conduit (3) in constant communication with the external environment. Said additional opening (5) is preferably positioned in an upper area (41) of the roller at a suction opening (3).
Patent PT-1651596-E (PT)
Title: Novel derivatives of 4,4`-dithiobis-(3-aminobutane-1-sulfonates) and compositions comprising the same
Inventor: ROQUES BERNARD PIERRE
IPC: C07F9/30
Filed: 2004-08-06
Abstract: The invention relates to derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulfonates) of formula (1), of use for the treatment and prevention of primary and secondary arterial hypertension.
Patent PT-1820516-E (PT)
Title: Novel albumin-free factor viii formulations
Inventor: BJORNSON ERIK
IPC: A61K38/43
Filed: 2000-02-22
Abstract: A Factor VIII composition formulated without albumin, comprising the following formulation excipients in addition to Factor VIII: 4% to 10% of a bulking agent selected from the group consisting of mannitol, glycine and alanine; 1% to 4% of a stabilizing agent selected from the group consisting of sucrose, trehalose, raffinose, and arginine; 1 mM to 5 mM calcium salt; 100 mM to 300 mM NaCl; and a buffering agent for maintaining a pH of approximately between 6 and 8. Alternatively, the formulation can comprise 2% to 6% hydroxyethyl starch; 1% to 4% of a stabilizing agent selected from the group consisting of sucrose, trehalose, raffinose, and arginine; 1 mM to 5 mM calcium salt; 100 mM to 300 mM NaCl; and a buffering agent for maintaining a pH of approximately between 6 and 8. In a further embodiment, the formulation can comprise: 300 mM to 500 mM NaCl; 1% to 4% of a stabilizing agent selected from the group consisting of sucrose, trehalose, raffinose, and arginine; 1 mM to 5 mM calcium salt; and a buffering agent.
Patent PT-1749517-E (PT)
Title: Stable pharmaceutical composition comprising linezolid form iv
Inventor: TENENGAUZER RUTH
IPC: A61K9/20
Filed: 2006-01-17
Abstract: A method of formulating linezolid to provide a solid pharmaceutical composition comprising linezolid Form IV substantially free of linezolid Form II, methods of treating a condition responsive to linezolid in a patient comprising administering to the patient a solid pharmaceutical composition comprising linezolid form IV substantially free of linezolid Form II.
Patent PT-1868786-E (PT)
Title: Method and system for comminuting and cleaning waste plastic
Inventor: HOFMANN MICHAEL
IPC: B29B17/02
Filed: 2006-03-21
Abstract: Method for comminuting and cleaning waste plastic, in particular, mixed plastic (MKS) with the following steps: a compacted material, especially, an agglomerate is produced from film scraps or film remnants comminuted into flakes and/or thick-walled plastic parts chopped up into chips, the compacted material is introduced into a disc or drum refiner and is ground therein in the presence of water, wherein the portion of compacted material of the goods located in the refiner amounts to at least 10 percent by weight, a fine grain fraction is removed from the ground stock exiting from the refiner, the remaining ground stock is washed and either mechanically dewatered and dried, or pulverized again in a further refiner stage in the presence of water, and subsequently dewatered and dried.
Patent PT-1977063-E (PT)
Title: A device for controlling a door
Inventor: TSUNG-CHIH CHANG
IPC: E05B41/00
Filed: 2006-11-17
Abstract: A device for controlling a door, the device having: a body; an electromagnet arranged to generate a magnetic field for retaining the door; a coupling that couples the electromagnet to the body, the coupling being arranged to allow a movement of the electromagnet relative to the body; and a current supply that is arranged to supply the electromagnet with a current. The current supply is arranged to detect the movement of the electromagnetic and to cease supplying the current at a predetermined instant after detecting the movement of the electromagnet.
Patent PT-2136788-E (PT)
Title: Cancer cell targeting using nanoparticles
Inventor: ZALE STEPHEN E
IPC: A61P35/00
Filed: 2008-03-31
Abstract: The present invention generally relates to polymers and macromolecules, in particular, to polymers useful in particles such as nanoparticles. One aspect of the invention is directed to a method of developing nanoparticles with desired properties. In one set of embodiments, the method includes producing libraries of nanoparticles having highly controlled properties, which can be formed by mixing together two or more macromolecules in different ratios. One or more of the macromolecules may be a polymeric conjugate of a moiety to a biocompatible polymer. In some cases, the nanoparticle may contain a drug. Other aspects of the invention are directed to methods using nanoparticle libraries.
Patent PT-2200210-E (PT)
Title: Method of transmitting and receiving a signal and apparatus for transmitting and receiving a signal
Inventor: KO WOO SUK
IPC: H04H20/76
Filed: 2009-12-07
Abstract: The present invention relates to method of transmitting and receiving broadcasting signal and a corresponding apparatus. One aspect of the present invention relates to a method of receiving broadcasting signal, wherein a C2 delivery system descriptor including an identifier of a PLP and an identifier of a C2 system in a TS loop of the NIT maps a transport stream to the data PLP in a data slice of the C2 system.
Patent PT-2358799-E (PT)
Title: Lubricant for thermoplastic polymers
Inventor: DAUTE PETER
IPC: C08K3/00
Filed: 2009-11-26
Abstract: The invention relates to a polymer composition, comprising at least one thermoplastic polymer, at least one pigment or at least one filler or a mixture thereof and at least one diester of a linear diol having 2 to 8 C-atoms with a linear or branched, saturated or unsaturated monocarboxylic acid having 6 to 44 C-atoms, wherein the fraction of diesters comprising different fatty acid radicals in a molecule is less than 10% by weight with regard to the total amount of diesters.
Patent PT-2357755-E (PT)
Title: Negotiation of sleep intervals in a network
Inventor: DESHPANDE MANOJ M
IPC: H04L12/12
Filed: 2007-03-02
Abstract: Techniques to improve the standby time of a station in a wireless network are described. An access point may advertise or convey a maximum listen interval and/or an association timeout supported by that access point. A station may operate in a power-save mode and may wake up every listen interval to receive a beacon and any potential traffic for the station. The station may select a suitable listen interval based on the maximum listen interval. The station may be dormant for a longer duration than the listen interval and may become active at least once in every association timeout in order to keep the association with the access point alive. The access point may also send broadcast and multicast traffic that might be of interest to stations in the power-save mode less frequently and using a special indication message.
Patent PT-638073-E (PT)
Inventor: BREGNEDAL PETER
IPC: C07D241/38
Filed: 1993-04-23
Abstract: Trans isomers of 1-piperazino-1,2-dihydroindene compounds having formula (I),    <IMAGE>  I  wherein X and Y are hydrogen, halogen, trifluoromethyl, alkyl, alkylthio, trifluoromethylthio, alkoxy, hydroxy, alkylsulfonyl, amino, alkylamino, nitro or cyano; Ar is a phenyl, thienyl or furyl group, each optionally substituted; R1 is hydrogen, or optionally hydroxy substituted alkyl, alkenyl, cycloalkyl or cycloalkylalkyl; R2 is alkyl, alkenyl, cycloalkyl, or cycloalkylalkyl; or R1 and R2 together form a 5 to 7-membered heterocyclic ring fused with the piperazine ring, which ring may be substituted with hydroxy; R3 is hydrogen, alkyl, alkenyl, cycloalkyl or cycloalkylalkyl; or R2 and R3 together form a 3 to 7-membered carbocyclic ring which is spiro-fused to the piperazine ring; and R4 is hydrogen or alkyl. The compounds of the invention have potent antagonist action on dopamine D1 receptors and are useful in the treatment of diseases of the central nervous system, such as psychoses, schizophrenia (positive as well as negative symptoms), anxiety, depression, sleep disturbances, migraine, Parkinson's disease or cocaine abuse.
Patent PT-666746-E (PT)
Inventor: LARDY HENRY A
IPC: A61P5/00
Filed: 1994-09-01
Abstract: A method for promoting weight control by treating a subject with a therapeutic amount of one of the  DELTA 5-androstenes listed below to stimulate weight control without affecting appetite or inducing the synthesis of sex hormones.  DELTA 5-Androstenes providing the desired biological activities include: (1)  DELTA 5-Androstene-3 beta ,7 alpha -diol-17-one, (2)  DELTA 5-Androstene-3 beta -ol-7,17-dione, (3)  DELTA 5-Androstene-3 beta ,7 alpha ,17 beta -triol, (4)  DELTA 5-Androstene-3 beta ,17 beta -diol-7-one, (5)  DELTA 5-Androstene-3 beta -acetoxy-7,16,17-trione, (6)  DELTA 5-Androstene-3 beta ,16 alpha -dihydroxy-7,17-dione, (7)  DELTA 5-Androstene-3 beta -propionoxy-16 beta -acetoxy-7,17-dione, (8)  DELTA 5-Androstene-3 beta ,7 alpha ,17 beta -triol-16-one, (9)  DELTA 5-Androstene-3 beta ,17 beta -diol-7,16-dione, (10)  DELTA 5-Androstene-3 beta ,16 alpha ,17 beta -triol-7-one and derivatives thereof wherein one or more of the hydroxyl or keto substituents is a group convertible thereto by hydrolysis.
Patent PT-758394-E (PT)
Inventor: BERND GRONER DR
IPC: A61K35/14
Filed: 1995-04-20
Abstract: A bifunctional protein comprising: 1) a single-chain antibody directed against a suitable antigen on a tumour cell, 2) a hinge region comprising from about 40 to about 200 amino acids joined to the V<SUB>L </SUB>domain of the single chain antibody, and 3) a functional zeta (zeta) chain from the T-cell antigen receptor (TCR) joined to the hinge region, wherein the hinge region is an immunoglobin-like hinge region which is joined to the C-terminus of the V<SUB>L </SUB>domain of the single-chain antibody. The functional zeta (zeta) chain comprises the transmembrane and the cytoplasmic domain. The bifunctional protein can be expressed using a cytotoxic lymphocyte (CTL) expressing DNA encoding it.
Patent PT-728743-E (PT)
Inventor: ROSENTRETER ULRICH
IPC: C07D209/88
Filed: 1996-02-14
Abstract: (3-amino)-tetrahydrocarbazole-propanoic acid esters of formula (I), and their salts, are new. R = alkyl contg. up to 10C.
Patent PT-747481-E (PT)
Inventor: MIDDELDORP JAAP MICHIEL
IPC: C12N15/38
Filed: 1996-05-28
Abstract: The invention relates to peptides or fragments thereof which are immunochemically reactive with Epstein-Barr Virus (EBV) antibodies. New antibodies directed to said peptides or fragments thereof are also part of the invention. The invention also relates to a method for the detection of EBV or antibodies directed against EBV in a test fluid and also to an immunochemical reagent comprising a peptide, a fragment or a polypeptide according to the invention and a test kit to be used when applying the said detection methods. Detection of EBV in a test fluid or tissue specimen using antibodies, monoclonal and polyclonal, directed to the said peptide, which have the characteristics of detecting both native and denatured EBV-EA protein is also part of said invention. <IMAGE>
Patent PT-745586-E (PT)
Inventor: LESIEUR DANIEL
IPC: C07C335/10
Filed: 1996-05-30
Abstract: Arylalkyl propylamide derivs. of formula (I), their enantiomers and diastereoisomers and their salts, are new except for N-Ä3-(4-hydroxy-naphth-1-yl)propylÜacetamide or N-Ä3-(4-benzyloxy-naphth-1-yl)propylÜacetamide. In (I), R1 = H, OH, R6 or OR6; R6 = e.g. opt. substd (cyclo)alkyl, opt. substd cycloalkylalkyl, alkenyl, alkynyl, cycloalkenyl, opt. substd phenyl etc.; R1' = R6', OR6', OH, COR7, CH2R7 or OCOR7; R6' = as R6; R7 = opt. substd 1-5C alkyl, opt. substd cycloalkyl or opt. substd cycloalkyl-(1-5C) alkyl, opt. substd phenyl etc.; Het A = e.g. dihydro- or tetrahydronaphthalene, naphthalene, benzothiophene etc.; n = 3-6; R2 = H or alkyl; R3 = C(=X)-R4 or C(=X)-NH-R5; X, X' = O or S; R4 = e.g. H, opt. substd. alkyl, alkenyl, alkynyl, opt. substd. cycloalkyl or opt. substd. cycloalkylalkyl; and R5 = H, opt. substd. alkyl, opt. substd cycloalkyl or opt. substd. cycloalkyl alkyl; with provisos.
Patent PT-988253-E (PT)
Inventor: HODGES ALASTAIR
IPC: B01J49/30
Filed: 1998-05-08
Abstract: A method of treating an ion exchange material, the method including: (a) positioning at least two regions of ion exchange material between an anode and cathode electrode, wherein at least a portion of the two regions being in electrical contact and being separated by a non-ion specific permeable interface; (b) supplying water to the at least two regions; (c) applying an electric potential between the electrodes thereby causing generation of hydrogen ions at the anode and hydroxide ions at the cathode, which ions are caused to move through each region towards the oppositely-charged electrode and thereby displacing at least a portion of any anions or cations associated with the ion exchange material in each region such that the displaced anions and cations are also caused to move through the regions towards the oppositely charged electrode; and (d) removing at least some of the cations and/or anions formed during step (c) which reach the interface.
Patent PT-1012096-E (PT)
Inventor: KEYSER HERBERT SYBRANT VAN DE
IPC: B65H23/02
Filed: 1998-09-08
Abstract: Film treatment surface provided with a propulsion system for circularly contoured film (5) along a circular path are disclosed. The essential propulsion and steering system is represented by two adjustable disks (2,3), one being equipped with a propulsion wheel and a steering mecanism whereas the second disk embodies an idler wheel and a steering mecanism. The treatment surface was found to be beneficially suitable for the manufacture of cut shaped blanks made from shaped films of plasticized polyvinyl butyral. The blanks can be used in automobile windshields. <IMAGE>
Patent PT-1054689-E (PT)
Inventor: BIRKETT ASHLEY J
IPC: A61K39/38
Filed: 1999-02-11
Abstract: A strategically modified hepatitis B core protein is described, where an insert is provided, preferably in an immunodominant region of the nucleocapsid protein, containing a chemically reactive amino acid residue. The modified hepatitis B core protein or its aggregated nucleocapsid protein particles can be pendently linked to a hapten to form a modified nucleocapsid conjugate. Such a conjugate is useful in the preparation of vaccines or antibodies. The modified hepatitis B core protein can also be modified to include a T cell epitope.
Patent PT-1066294-E (PT)
Inventor: BOOGERS ILCO ADRIANUS LAMBERTU
IPC: C07D463/20
Filed: 1999-03-26
Abstract: A method for the recovery of an N-substituted cephalosporanic acid compound of general formula (I), wherein R2 is selected from the group consisting of adipyl (1,4-dicarboxybutane), succinyl, glutaryl, adipyl, pimelyl, suberyl, 2-carboxyethyithio)acetyl, 3-carboxyethylthio)propionyl, higher alkyl saturated and higher alkyl unsaturated dicarboxylic acids, from a complex mixture comprising in addition to the compound of general formula (I) 6-aminopenicillanic acid (6-APA) and optionally one or more N-substituted penicillanic acid compounds, comprising the steps of: (a) acidifying the complex mixture to a pH below 6.5 and maintaining the mixture below said pH at a temperature of between 10° C. and 150° C.; and/or (b) contacting the complex mixture with a carbon dioxide source; and (c) recovering the cephalosporanic acid compound of formula (I) from the mixture obtained after steps (a) and/or (b).
Patent SG-76988-G (SG)
Title: Human immune interferon and its production by recombinant dna technology
IPC: C07K1/00
Filed: 1988-11-17
Abstract: Disclosed is a complete description of the preparation of a novel, substantially pure polypeptide via recombinant DNA techniques utilizing any of an assortment of expression vectors and host cultures. The polypeptide, human immune (gamma) interferon (IFN- gamma ), is isolated in substantially pure form and characterized in terms of DNA and amino acid sequences, physical attributes and biological activity.